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Abstract This paper describes modifications of the
standard methods for obtaining a soluble nuclear fraction
from embryonic brain tissue. The main improvements are:
(1) the inclusion of a low speed centrifugation step to
prevent the appearance of high density contaminants, (2) a
sucrose density gradient to remove perinuclear mitochon-
dria and ER membranes and (3) a protein extraction
approach which significantly enhances protein yield. To
demonstrate the effectiveness of the method, pellets were
analyzed by light and electron microscopy and purity of the
soluble extracts was immunologically tested. Finally, to
illustrate the applicability of this approach, the induction of
the transcription factor HIF-1 (hypoxia-inducible factor-1)
was assessed by Western blot using soluble nuclear frac-
tions and by immuno-electron microscopy using purified
nuclear fractions, both obtained from the optic lobes of
chick embryos. In conclusion, the procedure presently
described appears to be reliable and convenient for
obtaining a pure soluble nuclear fraction from a discrete
amount of embryonic brain tissue.
Keywords Subcellular fractionation 
Soluble nuclear fraction  Embryonic brain tissue 
Transcription factors  Western blot
Introduction
Signaling to living cells by growth factors, hormones,
transmitters and stress stimuli leads to a modulation of
gene expression via several molecular mechanisms. Tran-
scription factors integrate different signaling networks and
are therefore at the center of the adaptive response of cells
[1]. As a result, understanding cellular responses depends
largely on the assessment of the intensity and kinetics of
the activation of transcription factors. Both aspects can be
determined by Western blotting, a simple and reliable
experimental approach. In this context, the preparation of a
soluble nuclear fraction (SNF) is often required as a first
step.
Several problems arise when the source tissue is derived
from embryonic brain structures. Embryos are too small to
be perfused and despite extensive rinsing of the dissected
material, crude nuclear pellets contain large amounts of red
blood cells, fragments of capillaries, intact cells and other
debris of relatively large size and high density. Besides,
low density contaminants like endoplasmic reticulum (ER)
fragments and mitochondria, are also found in the nuclear
fraction. Together, these contaminants add variability to
the results and contribute to mask subtle signals, especially
when the inactive transcription factor is immunologically
indistinguishable from the active form and is present in
other subcellular compartment.
In order to solve these problems we developed a frac-
tionation procedure based on consideration of a large
number of reports concerning both the purification and
protein extraction from nuclei. The purification of nuclei
proposed here resembles the procedure first described by
Blobel and Potter [2], but with major modifications. A low
speed centrifugation step immediately after homogeniza-
tion (and before nuclear pelleting) minimized the number
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of red blood cells and the amount of debris contamination.
The next step in this isolation procedure was the sedi-
mentation of nuclei through a sucrose solution with suffi-
cient density to float the ER and mitochondria while
pelleting the nuclei. During this procedure, as nuclei move
down through the sucrose solution, the ER moves upward
and is stripped from the nuclei without significantly
affecting their integrity.
For extraction of nuclear proteins, we used a treatment
with high salt and detergent combined with shearing
through a syringe. This procedure fragments the DNA and
releases the majority of proteins [3]. Importantly, we found
that the addition of a low concentration of sodium dodecyl
sulphate (SDS) as a complement of the classical Triton-
X-100 significantly improved protein yield.
To demonstrate the effectiveness of the proposed
method, morphology of the pellets was analyzed by light
and electron microscopy, and purity of the soluble extracts
was immunologically tested using subcellular specific
markers.
Finally, to illustrate the applicability of this approach,
the induction of the transcription factor HIF-1 (hypoxia-
inducible factor-1) was assessed by Western blot using
SNFs and by immuno-electron microscopy using purified
nuclear fractions (PNFs), both obtained from the optic
lobes of chick embryos (bilateral mesencephalic structures
involved in visual processing).
Experimental Procedures
Animals
White Leghorn fertile chicken (Gallus gallus domesticus)
eggs were obtained from a local hatchery and incubated at
37C and 60% relative humidity. They were sacrificed at
embryonic day 12.
Soluble Nuclear Fraction
The complete procedure, outlined in Fig. 1, includes the
isolation of nuclei and posterior nuclear protein extraction.
Working Solutions
Buffer A: 0.32 M sucrose, 20 mM Tris–HCl (pH 7.4),
1 mM EDTA, 1 mM EGTA, 1 mM DTT, 75 lg/ml sper-
midine; phosphatase inhibitors: 50 mM NaF, 1 mM
Na3VO4, 1 mM ammonium molybdate; protease inhibitors:
1 lM leupeptin, 1 lM aprotinin, 1 lM pepstatin A and
1 lM PMSF. DTT, spermidine and protein inhibitors
should be added just prior to use.
Buffer B: 1.6 M sucrose, 20 mM Tris (pH 7.4), 5 mM
MgCl2, 1 mM DTT, 75 lg/ml spermidine and 1 lM
PMSF. DTT, spermidine and PMSF should be added just
prior to use.
Buffer C: 0.32 M sucrose, 20 mM Tris–HCl (pH 7.4).
Buffer D: 20 mM HEPES (pH 7.9), 0.5 M NaCl,
1.5 mM MgCl2, 0.2 mM EDTA, 1% v/v Triton-X-100,
0.025% w/v SDS, 1 mM DTT, 1 lM PMSF and 20%
glycerol. DTT and PMSF should be added just prior to use.
PBS: phosphate-buffered saline, 0.007 M Na2HPO4,
0.003 M NaH2PO4, 1.3 M NaCl (pH 7.4).
Buffers can be stored at 4C for 2 weeks.
Isolation of Nuclei
1. Chick embryos were sacrificed by decapitation and
optic lobes were quickly removed and placed in ice-
cold PBS.
2. Optic lobes from six embryos (*0.6 g) were pooled
and homogenized in buffer A (1/10 w/v) in a Potter–
Elvehjem homogenizer.
3. The homogenate was centrifuged at 75g (1,000 rpm
using a Sorvall SS-34 rotor) for 4 min. Care should be
taken to avoid disturbing the loose reddish pellet
containing high density contaminants (HDC) while
removing and saving the supernatant (S1).
4. S1 was centrifuged at 900g (2,750 rpm using a Sorvall
SS-34 rotor) for 10 min. Following centrifugation, the
new supernatant S2 was removed and the pellet (P1) was
washed by rapid rehomogenization in buffer A and
centrifuged again. The new pellet, the nuclear enriched
fraction (NEF), is whitish and more compact than HDC.
5. NEF was resuspended in 6 ml (3 ml of buffer A and
3 ml of buffer B) and homogenized with two strokes of
the homogenizer. The final sucrose concentration of
the solution is *1 M.
6. The resuspended NEF was layered onto a 6 ml sucrose
cushion of buffer B in a SW28 ultracentrifuge tube.
Tubes should be completely filled during centrifuga-
tion to avoid collapsing. Buffer C is layered onto the
sample to complete the volume of the tubes.
7. Samples were centrifuged at 80,000g (24,500 rpm) in
a Beckman SW28 rotor for 35 min. Following centri-
fugation a Pasteur pipette is used to remove a layer of
whitish membranous material formed between the
1 M/1.6 M density step. The remaining supernatant
was poured off by rapidly inverting the tubes. Purified
nuclei remain as a tight, opaque pellet at the bottom of
the tubes (P2).
8. P2 was resuspended in 0.5 ml of buffer A, placed in a
1.5-ml microcentrifuge tube, and pelleted by a quick
spinning (30 s) in a microcentrifuge. This pellet
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containing isolated nuclei is the PNF. PNF can either
be processed immediately for protein extraction or be
frozen and stored at -80C.
Nuclear Protein Extraction
1. PNF was resuspended in 0.5 ml of buffer D and
incubated for 30 min with gentle rocking at 4C.
2. Nuclei were completely lysed with ten passages
through an 18-gauge needle.
3. Samples were centrifuged at 9,000g for 30 min in a
microcentrifuge.
4. The supernatant, the SNF, was aliquoted and stored at
-20C, while the insoluble fraction (IF) pellet was
discarded.
Protein content of the SNF was assessed as described by
Lowry [4].
HIF-1 Induction
The divalent metal salt cobalt chloride (CoCl2), a known
inducer of HIF-1 was used [5]. At embryonic day 11 eggs
were windowed following a modification of the Hamburger
procedure [6]. Briefly, a rectangular area of the shell roughly
4–6 mm2 in size was removed and the window was covered
with Micropore tape (3 M). In embryonic day 12, 1 h before
sacrifice, the tapes were removed and 100 ll of a CoCl2
solution or vehicle (saline) were applied to the vascularised
chorioallantoic membrane. A concentration of 0.1 mM of
CoCl2 was used considering a final volume of 50 ml/egg.
Fig. 1 Schematic diagram
illustrating the method
described in this study to obtain
a soluble nuclear fraction (SNF)
from embryonic brain tissue.
Dashed line: modified version
of the method to demonstrate
the effect of the sucrose cushion
step in the purity of the protein
extract (see ‘‘Results’’).
P, pellet; S, supernatant; HDC,
high density contaminants;
NEF, nuclear enriched fraction;
PNF, purified nuclear fraction;
IF, insoluble fraction; ISNF,
impure soluble nuclear fraction
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The above protocol follows the Guide for the Care and
use of Laboratory Animals from the Institute of Laboratory
Animals Resources, Commission of Life Sciences,
National Research Council, USA (NIH Publication
No. 80-23, revised 1996). The number of animals used was
minimized accordingly.
Microscopy
HDC, NEF, PNF and IF were fixed in cold 4% parafor-
maldehyde w/v and 0.5% w/v glutaraldehyde dissolved in
0.1 M phosphate buffer (pH 7.2–7.4) for 2 h at 4C. Each
sample was then postfixed in the same buffer solution
supplemented with 1% w/v osmium tetroxide. After two
15 min washes with distilled water, samples were
immersed for 2 h in 5% (w/v) uranyl acetate and imme-
diately dehydrated and embedded in a water-soluble ali-
phatic polyepoxide (Durcupan Fluka AG, Chemische
Fabrik, Buschs SG, Switzerland).
For light microscopy analysis semithin (1 lm), toluidine
blue stained sections were photographed in a Zeiss Axi-
ophot microscope equipped with a digital cooled camera.
For electron microscopy, ultrathin sections (70–90 nm)
were contrasted with Reynolds’ lead citrate [7] and then
observed and photographed with a C10 Zeiss Electron
Microscope.
For immunoelectron microscopy, PNFs were fixed as
above but the embedment was in LR-White (London Resin
Co. Hampshire, UK). Ultrathin sections were mounted on
nickel grids and nonspecific binding sites were blocked by
incubating the sections for 45 min on a drop of 0.2% BSA
and 0.1% Tween 20 in PBS at RT. After a short rinse in
PBS, grids were incubated onto a drop of primary mouse
anti-HIF-1a (diluted 1/20) in a moist chamber at 4C
overnight. After three short rinses in PBS, sections were
incubated with secondary 10 nm gold-coupled goat anti-
mouse antibody (Sigma-Aldrich Co. St. Louis, MO) diluted
1/50 for 1 h. The sections were then stained with uranyl
acetate and lead citrate. Quantification of immunogold
labelling was performed by a blinded investigator. The
negative control, omitting the primary antibody, produced
no labelling.
Western Blotting
Soluble nuclear fractions were denatured in loading buffer
(62.5 mM Tris–HCl pH 6.8, 2% SDS, 10% b-mercap-
toethanol, 10% glycerol, 0.002% bromophenol blue) at
100C for 10 min and then separated by electrophoresis on
a SDS-polyacrylamide gel (Bio-Rad, Richmond, CA) at
10% for HIF-1a and calnexin or 18% for histone H3 and
cytochrome c. Proteins were then transferred to a PVDF
membrane (Millipore Corporation, MA, USA). After
blocking in 4% milk in phosphate-buffered saline with
Tween 20 (T 0.05% in PBS 19) for 1 h, membranes were
incubated with the primary antibody overnight at 4C fol-
lowed by HRP-conjugated secondary antibodies (Chem-
icon International, Inc., CA, USA). For primary antibodies
the dilutions used were 1:1,000 for anti-HIF-1a, anti-
cytochrome c and anti-histone H3 monoclonal antibodies
(Chemicon International, Inc., CA, USA) and 1:1,500
dilution for the anti-calnexin polyclonal antibody (a gift
from J. Caramelo). A microsomal fraction and a pure
mitochondrial fraction obtained from ED12 chick optic
lobes [8] were, respectively, used as positive control for
calnexin and cytochrome c.
Bands were detected by chemiluminescence using ECL
Kit (Amersham Pharmacia Biotech). Optical density of the
radioautograms was quantified with Gel-Pro Analyzer 3.1.
Results
The Low Speed Centrifugation Step Removes High
Density Contaminants
Morphology assessment of HDC showed a large number of
red blood cells (nucleated in avian species), fragments of
capillaries and intact cells (Fig. 2a–b). In contrast, these
high density contaminants were not found after the low
speed centrifugation step in NEF and PNF (Fig. 2c–d).
Density Sedimentation Step Removes ER and
Mitochondrial Membranes from Nuclei
Electron microscopy analysis revealed that mitochondria
and perinuclear membranes (fragments of ER) were
detected in nuclei from NEF (Fig. 2c) but not observed
after the density sedimentation step in PNF (Fig. 2d).
In order to further confirm the effectiveness of the
density sedimentation step, two soluble protein extracts
were compared. One of them was prepared with NEF and
the other with PNF, yielding ISNF and SNF, respectively
(Fig. 1). Those extracts reflect the protein content of pellets
before and after the density sedimentation step. The purity
of the soluble fractions was assessed by western blot using
subcellular specific markers. Both fractions were positive
for nuclear marker histone H3, but ISNF also had
remarkable higher amounts of the ER marker calnexin and
the mitochondrial marker cytochrome c (Fig. 3).
SDS Improves Protein Yield During the Extraction
The effect of SDS low concentration on the protein
extraction step was tested by comparing protein yield
obtained with or without SDS in the extraction buffer
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(buffer D). We found that protein extraction from PNF was
improved by the use of a low concentration of SDS
(Table 1). With this procedure protein extraction was
extensive and IF had ultrastructural morphologies com-
patible with chromatin fibers (Fig. 2e). In order to avoid
artifacts in the quantification, protein extracts obtained
without SDS were added with the same amount of this
detergent as the other samples before protein measurement.
Composition of buffer D in ‘‘Experimental Procedures’’
reflects the SDS containing variant.
PNF and SFN are Suitable to Assess the Activation
of Transcription Factors
To demonstrate that PNF and SFN obtained with the pro-
cedure described above were suitable to assess the activa-
tion of transcription factors in embryonic brain tissue, we
Fig. 2 Morphologic analysis of
the pellets. a Light micrograph
of a representative sample of
HDC containing significant
amounts of high density
contaminants: Red blood cells
appearing as dark bodies
(arrowheads), intact cells
(asterisks) and fragments of
capillaries (arrows)
occasionally including a red
blood cell. Only some of these
components are indicated in the
micrograph. Scale bar, 15 lm
(b–e) electron micrographs of
the pellets. b HDC showing a
red blood cell and intact cells.
Scale bar, 500 nm. c The
nuclear enriched fraction, NEF,
showing nuclei with perinuclear
membrane contaminants and
some mitochondria (arrows).
Scale bar, 200 nm. d Pure
isolated nuclei in PNF. Scale
bar, 250 nm. e IF containing
insoluble chromatin fibers after
extensive extraction. Scale bar,
25 nm
Fig. 3 Representative immunoblotting of SNF and ISNF revealed
with subcellular specific antibodies: anti-histone H3 (nuclear), anti-
calnexin (ER) and cytochrome c (mitochondrial). A microsomal
fraction and a pure mitochondrial fraction were, respectively, used as
positive controls (C?) for calnexin and cytochrome c
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used the well-described induction of the transcription fac-
tor HIF-1 by CoCl2. This activation was determined by two
different approaches. First, PNF was subjected to an
immune-EM analysis. Quantification of gold particles
revealed a significant increase in HIF-1a levels after in
vivo CoCl2 treatment compared to vehicle-treated embryos
(Fig. 4). Second, HIF-1a was detected by western blot of
SNFs obtained from optic lobes of chick embryos. As
expected, and in line with the immune-EM results, we
found significantly increased HIF-1a levels when CoCl2
was administered to the embryos 60 min before decapita-
tion (Fig. 5).
Discussion
This paper describes modifications of the standard methods
for obtaining a SNF from embryonic brain tissue. The main
improvements of this procedure are: (1) the inclusion of a
low speed centrifugation step to prevent the appearance
high density contaminants such as red blood cells, frag-
ments of capillaries and intact cells, (2) a modification of
the Blobel and Potter [2] sucrose density gradient to
remove ER and mitochondrial membranes and (3) a protein
extraction approach based on shear stress, high salt and a
combination of two classes of detergents, which enhances
protein yield.
Morphological examination of HDC evidenced the
importance of the low speed centrifugation as a key step
to prevent the appearance of high density contaminants
(Fig. 2a–b). The following step, the sucrose cushion,
showed to be effective to remove perinuclear ER fragments
and mitochondria, as electron microscopy of PNF revealed
a preparation with little or no membrane contamination
(Fig. 2d). In addition, western blot analysis of nuclear, ER
and mitochondrial markers in SNF derived from PNF
suggest that this step yields a purified sample (Fig. 3).
The density of the sucrose cushion is a critical param-
eter. If it is too low it will not remove contaminating
membranes, while if it is too high it will not allow the
pelleting of nuclei. In the original report [2], the density
was set at 2.3 M for adult rat liver preparations and dif-
ferent combinations of density steps to isolate nuclei are
described in the literature. Many experimental procedures
use a 2 M sucrose cushion [9, 10]. However, nuclei of
several sources are not dense enough to pass through this
cushion, resulting in poor yields of purified nuclei. Several
reports have suggested that the appropriate sucrose step is
tissue dependent [11, 12] but it has not yet been described
for embryonic brain tissue. In this study, we found that a
1 M/1.6 M density step was suitable for embryonic brain
tissue. Furthermore, small increases above 1.6 M led to a
marked decrease of nuclear yield (data not shown).
Other experimental approaches for preparing nuclear
extracts are based on the method of Dignam [13, 14] which
consists of an extraction of proteins from a crude nuclear
pellet with a high salt solution. Other studies use as nuclear
extracts samples derived from a high salt extraction from a
tissue homogenate [15] containing a significant contami-
nation of cytoplasmatic components. Neither of these
systems removes high density or perinuclear membranous
contaminants.
The protein extraction step from purified nuclei used
in this study takes advantage of the high salt extraction
Fig. 4 Immunogold labelling of HIF-1a using PNF. a Electron
micrograph of a representative sample of PNF subjected to immuno-
EM analysis. Scale bar, 300 nm. b Detail of a nucleus showing gold
immunolabeling (10 nm) with antibodies specific for HIF-1a. Scale
bar, 100 nm. c Quantitative analysis showed significative differences
between CoCl2 and control (vehicle-treated) embryos (** P \ 0.01,
Student’s t-test). 50 nuclei were analyzed in each condition
Table 1 Effect of SDS on protein yield
Protein yield (mg/g wet tissue) Change (%)
Without SDS 1.18 ± 0.12 –
With SDS 1.49 ± 0.17** 26.3
Nuclear protein extraction was performed with or without SDS in the
extraction buffer (Buffer D). Values are means ± SEM of n = 4
independent experiments (** P \ 0.01, Student’s t-test)
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procedure to precipitate DNA. Detergents are also used in
the extraction. Several studies have demonstrated that
many proteins remain in the IF after nuclear protein
extraction when non ionic detergents are used [16–18]. As
mentioned above, an improvement of the method described
here is the use of a low concentration of the ionic detergent
SDS, which increased protein yield by *25% (Table 1)
when compared to the use of the non ionic Triton-X-100
alone. The use of SDS does not interfere when SNF is
subjected to electrophoresis, since in this technique the
loading buffer typically contains SDS concentrations 80
times higher than that used in the extraction buffer.
The use of PNF and SNF from embryonic brain tissue in
the study of transcription factors is demonstrated in this
report using HIF-1 as an example (Figs. 4, 5). The tran-
scription factor HIF-1 is a heterodimer composed of an
O2-regulated HIF-1a subunit and a constitutively expressed
HIF-1b subunit [19] that has an essential role in the
maintenance of oxygen homeostasis in metazoan organ-
isms. O2-dependent degradation of HIF-1a is triggered by
the hydroxylation of specific proline residues by the prolyl
hydroxylase PHD2 [20]. Under hypoxic conditions, PHD2
activity is reduced as a result of substrate limitation [21]
leading to HIF-1a accumulation. Then, HIF-1a dimerizes
with HIF-1b, and together translocate to the nucleus, where
they increase the transcription of target genes. It has been
established that HIF-1a accumulation can also result from
the inhibition of the catalytic center of PHD2 (which
contains Fe2?) by divalent metal cations such as Co2? [5].
Therefore, the accumulation of HIF-1a in the nucleus is
used as an indicator of HIF-1 induction, as in the present
approach.
In conclusion, the procedure presently described appears
to be reliable and convenient for obtaining of a pure SNF
from a discrete amount of embryonic brain tissue. This
fraction is suitable for the analysis of transcription factors
by Western blot. Additionally, this protocol could be used
to study developmental changes in nuclear protein content
or modifications resulting from pharmacological or elec-
trophysiological experiments.
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